Cannabis and tolerance: Acute drug impairment as a function of cannabis use history

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ramaekers, J G ^a   Van Wel, J H ^a   Spronk, D B ^b   Toennes, S W ^c   Kuypers, K P C ^a   Theunissen, E L ^a   Verkes, R J ^b,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c GOETHE UNIVERSITY   (Germany)

^d Pompestichting   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DRONABINOL;

ACUTE DISEASE; ADOLESCENT; ADULT; ATTENTION; CANNABIS ADDICTION; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITION; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DEMENTIA ASSESSMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; DRUG TOLERANCE; DRUG USE; EXECUTIVE FUNCTION; FEMALE; HABIT; HUMAN; IMPULSIVENESS; MALE; MULTICENTER STUDY; NETHERLANDS; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; ATTENTION; COCAINE; COCAINE-RELATED DISORDERS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRONABINOL; DRUG TOLERANCE; DRUG USERS; EXECUTIVE FUNCTION; FEMALE; HABITS; HUMANS; IMPULSIVE BEHAVIOR; MALE; MARIJUANA ABUSE; MENTAL STATUS AND DEMENTIA TESTS; NETHERLANDS; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84971212641     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26843     Document Type: Article

References (36)

1. Degenhardt, L. et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLos medicine 5, e141 (2008).
2. Hall, W., Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 374, 1383-91 (2009).
3. Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E. (2014). Monitoring the future. National surrvey results on drug use 1975-2014 (NIDA, 2014).
4. Hall, W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 110, 19-35 (2015).
5. Ramaekers, J. G., Berghaus, G., van Laar, M., Drummer, O.H. Dose related risk of motor vehicle crashes after cannabis use. Drug and alcohol dependence 73, 109-19 (2004).
6. Hartman, R. L., Huestis, M. A. Cannabis effects on driving skills. Clin Chem 59, 478-92 (2013).
7. Asbridge, M., Hayden, J. A., Cartwright, J. L. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 344, e536 (2012).
8. Curran, H. V., Brignell, C., Fletcher, S., Middleton, P., Henry, J. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164, 61-70 (2002).
9. Ramaekers, J. G. et al. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 31, 2296-303 (2006).
10. Gonzalez, R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev 17, 347-61 (2007).
11. Crean, R. D., Crane, N. A., Mason, B. J. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5, 1-8 (2011).
12. Bossong, M. G., Jager, G., Bhattacharyya, S., Allen, P. Acute and non-acute Effects of Cannabis on Human Memory Function: a Critical Review of Neuroimaging Studies. Curr Pharm Des 20, 2114-25 (2014).
13. Crane, N. A., Schuster, R. M., Fusar-Poli, P., Gonzalez, R. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 23, 117-37 (2013).
14. Ramaekers, J. G. et al. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug and alcohol dependence 85, 114-22 (2006).
15. Mendelson, J. H. et al. Behavioral and biologic aspects of marijuana use. Ann N Y Acad Sci 282, 186-210 (1976).
16. Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., Fischman, M. W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141, 385-94 (1999).
17. Kirk, J. M., de Wit, H. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 63, 137-42 (1999).
18. Nowlan, R., Cohen, S. Tolerance to marijuana: heart rate and subjective "high". Clin Pharmacol Ther 22, 550-6 (1977).
19. Hart, C. L., van Gorp, W., Haney, M., Foltin, R. W., Fischman, M. W. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 25, 757-65 (2001).
20. Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., Moeller, M. R. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of psychopharmacology 23, 266-77 (2009).
21. Hart, C. L. et al. Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav 96, 333-41 (2010).
22. Ramaekers, J. G. et al. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology 214, 391-401 (2011).
23. Desrosiers, N. A., Ramaekers, J. G., Chauchard, E., Gorelick, D. A., Huestis, M. A. Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. J Anal Toxicol 39, 251-61 (2015).
24. Metrik, J. et al. Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology 223, 489-99 (2012).
25. van Wel, J. H. et al. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. Br J Pharmacol 170, 1410-20 (2013).
26. Armentano, P. Cannabis and psychomotor performance: a rational review of the evidence and implications for public policy. Drug Test Anal 5, 52-6 (2013).
27. Shallice, T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 298, 199-209 (1982).
28. Logan G. D., Cowan W. B., KA, D. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10, 276-91 (1984).
29. Jex, H. R., McDonnell, J. D., AV, P. (1966). A critical tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. (NASA CR-616. NASA Contract Rep NASA CR: 1-105, 1966).
30. Toennes, S. W., Steinmeyer, S., Maurer, H. J., Moeller, M. R., Kauert, G. F. Screening for drugs of abuse in oral fluid-correlation of analysis results with serum in forensic cases. J Anal Toxicol 29, 22-7 (2005).
31. Toennes, S. W., Ramaekers, J. G., Theunissen, E. L., Moeller, M. R., Kauert, G. F. Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32, 470-7 (2008).
32. Spronk, D. B., van Wel, J. H., Ramaekers, J. G., Verkes, R. J. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev 37, 1838-59 (2013).
33. Vadhan, N. P. et al. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol 29, 357-64 (2007).
34. Bosker, W. M. et al. Medicinal Delta(9)-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests. Addiction 107, 1837-44 (2012).
35. Theunissen, E. L. et al. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology 220, 341-50 (2012).
36. Schwope, D. M., Bosker, W. M., Ramaekers, J. G., Gorelick, D. A., Huestis, M. A. Psychomotor performance, subjective and physiological effects and whole blood Delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. Journal of analytical toxicology 36, 405-12 (2012).